
Is climate change increasing the levels of toxic arsenic in our rice?
Scientists have known for a while now that a lot of rice contains some amount of arsenic. A new study that was published in The Lancet Planetary Health last month, however, had some newer, more worrying findings: it found that with rising carbon emissions and rising temperatures, the arsenic levels in rice will rise. The study was conducted over a 10-year period on 28 different strains of paddy rice at four different locations in China. Arsenic is a known carcinogen – it is linked to cancers including lung and bladder cancer as well as to other serious health conditions.
So what does this study mean for India, which is a large rice-growing and rice-eating country and one that is also experiencing climate change effects? What does arsenic do to your body in the long term? Are there methods to grow rice that decrease the amount of arsenic in it? What can you do to make the rice you are eating at home safer?
Guests: Lewis Ziska, associate rofessor, environmental health sciences, Mailman School of Public Health, Columbia University and Keeve Nachman, professor of environmental health and engineering, Johns Hopkins Bloomberg School of Public Health
Host: Zubeda Hamid
Edited by Jude Francis Weston
Listen to more In Focus podcasts:
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
4 hours ago
- Hans India
Prevention, not just medication, key to tackling obesity and diabetes: Jitendra Singh
Union Minister Jitendra Singh on Sunday stressed that prevention should be the main focus in tackling obesity and diabetes, rather than depending only on medication. He said that lifestyle changes, awareness, and scientifically backed information are crucial to address the growing health challenge of metabolic disorders in India. Dr. Singh, who is also a renowned diabetologist and professor of medicine, was speaking at the launch of the book 'The Weight Loss Revolution – Weight Loss Drugs and How to Use Them' authored by endocrinologist Dr. Ambrish Mithal along with journalist Shivam Vij. The Minister noted that India, once known as the diabetes capital of the world, is now also emerging as the obesity capital, ranking third globally in childhood obesity. He warned against the unchecked spread of disinformation through unscientific diet charts and fad regimens, saying diet plans must always be based on scientifically validated principles. Dr. Singh emphasised the importance of 'Indian solutions for Indian patients' and pointed out that central obesity -- fat around the abdomen -- poses a more serious risk for Indians compared to Western populations. Sometimes, he said, 'a simple inch tape around the waist may be more meaningful than a BMI chart.' Highlighting the role of lifestyle interventions, Dr. Singh said studies in India show that regular yoga practice can reduce the risk of type-2 diabetes by up to 40 per cent. He called for a holistic approach that combines lifestyle modification, modern medicine, and traditional practices. On the use of new weight loss drugs like Ozempic and Mounjaro, Dr. Singh advised caution, saying clinical outcomes take years to establish. He compared it with the refined oil episode in India, where hasty conclusions later proved misleading. Dr. Singh also reminded that with over 70 per cent of India's population below 40 years of age, the country cannot afford to let lifestyle diseases affect its youth. Prevention-driven strategies, he said, are vital to protect the potential of the younger generation. Quoting Mark Twain, he remarked, 'Economics is too serious a subject to be left to an economist,' and added that obesity and diabetes are too serious to be left only to doctors. Unless there is mass awareness, he said, optimum results in tackling these diseases will not be possible. The Minister praised Dr. Mithal's book as timely and authoritative, saying it will help both medical professionals and the public separate facts from misinformation in an era dominated by social media and quick fixes.


The Hindu
7 hours ago
- The Hindu
From Obesity to Ozempic: Is This the Right Way to Lose Weight?
The food landscape has undergone a dramatic shift over the years, and the numbers tell a sobering story. A study in The Lancet found that childhood and adolescent obesity rates worldwide have risen nearly fourfold from 1990 to 2022, while adult obesity rates have more than doubled. At the same time, dramatic celebrity weight loss has been linked to Ozempic, an injectable drug containing semaglutide, originally developed to treat type 2 diabetes but now widely used off-label as a weight-loss aid. In this weekender episode of In Focus, we ask: Why is it becoming harder to lose weight? What role do our gut and brain play in shaping our relationship with food? And should drugs like Ozempic step in where lifestyle changes and willpower fall short? Guest: Dr Jack Mosley, the author of Food Noise: How weight loss medications & smart nutrition can silence your cravings Host: Preeti Zechariah Edited by Jude Francis Weston and Sharmada Venkatasubramanian


News18
14 hours ago
- News18
Organ Donation Myths, Realities And The Future Of Kidney Transplants In India
According to Indian Council of Medical Research, 10.1 crore Indians are diabetic. WHO estimates that around 2.5 crore Indians are prediabetic at high risk of developing diabetes We are currently facing a silent epidemic of non-communicable diseases (NCDs), with diabetes mellitus (DM) leading the charge. According to the ICMR (Indian Council of Medical Research), 10.1 crore Indians are diabetic. The WHO estimates that around 2.5 crore Indians are prediabetic at high risk of developing diabetes. Hypertension, or high blood pressure, is also extremely common, affecting an estimated 22–23% of Indians. Together, these two silent diseases are the leading causes of chronic kidney disease (CKD). Various researchers have pegged the prevalence of CKD in India between 10–17%, and these numbers are alarming. Dr Tanmay Pandya, HOD & Director, Nephrology & Renal Transplantation, Sarvodaya Hospital, Sector-8, Faridabad shares all you need to know: While CKD spans a broad spectrum, the most dreaded stage is kidney failure, also known as End-Stage Kidney Disease (ESKD), where most patients require kidney replacement therapy. In India, over 3 lakh new patients are diagnosed with ESKD annually and require some form of kidney replacement therapy. Globally, available options include either dialysis or kidney transplantation. Considering quality of life, life expectancy, and financial impact, kidney transplantation is clearly the preferred modality especially in the resource-limited settings of India. For transplantation, the foremost requirement is a donor kidney. This may come from organ donation at the time of brain death, or, more commonly in India, from another person. In our society, owing to several reasons, donation from a living, related donor is the primary source of kidneys for transplantation. The process is governed by the Transplantation of Human Organs Act, passed by Parliament and implemented across states and union territories. Humans have two kidneys working seamlessly as a single unit, providing one of the most efficient organ systems in the body. Remarkably, if one kidney is removed for some reason, the other can largely compensate. For a healthy person, the impact of removing one kidney is negligible. This forms the rationale for kidney donation from a living donor. Several studies have addressed the health implications of organ donation and concluded that the practice is safe when the donor is carefully selected. One calculation shows the risk of developing CKD after donation is only 0.24% higher compared to non-donors, a minuscule, medically and ethically acceptable number. Similarly, living liver donation is also largely safe, as the liver can regenerate the donated segment within months, leaving practically no long-term impact. That said, living donors do face short- and long-term risks, primarily related to surgery. Donor selection is therefore a meticulous, rigorous process involving multi-speciality consultation and a battery of investigations to ensure safety. Only when a donor is deemed fit is the donation approved. Post-surgery, recovery is similar to other major operations. Most donors can return to routine activities within two weeks, though heavy physical work should be avoided for a while longer. Donors are counselled to adopt a healthier lifestyle, including regular exercise, balanced nutrition, and complete avoidance of smoking and alcohol. Periodic health checkups are mandatory to ensure long-term safety. Despite its safety, the donor pool remains small for any given patient. Generally, only close relatives are accepted as donors, but incompatibility such as mismatched blood groups or tissue types often creates challenges. Treatments exist to overcome these incompatibilities, but they come with added costs and risks. An innovative solution is kidney swap transplantation. In this system, two or more donor–recipient pairs are matched to overcome incompatibility and achieve successful transplantation. Swap transplants are legally permitted in most Indian states, and organisations like the Indian Society of Organ Transplantation (ISOT) and the National Organ & Tissue Transplantation Organisation (NOTTO) actively promote them. Multi-way swaps sometimes involving up to 10 pairs have been successfully performed in India. Institutions such as IKDRC, Ahmedabad, routinely conduct 100–150 swap transplants per year. ISOT has also developed software to help doctors find suitable matches. Swap transplantation has thus emerged as a life-saving alternative in kidney transplantation in India, significantly expanding the donor pool and utilising available donors more effectively. First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.